PL2206500T3
A solid pharmaceutical dosage formulation comprising lopinavir
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 21 February 2026, 0.6 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
2 sheets
Sheet 1 Sheet 2
10 priority claims, no other members on record
Priority claims10
| Document | Office | Kind | Date |
|---|---|---|---|
| 6446705 | United States of America | A | |
| 6446705 | United States of America | A | |
| 06735552 | European Patent Office (EPO) | A | |
| 06735552 | European Patent Office (EPO) | A | |
| 10159672 | European Patent Office (EPO) | A | |
| 101596724 | – | – | – |
| 64467 | – | – | – |
| EP20060735552 | – | – | – |
| EP20100159672 | – | – | – |
| US20050064467 | – | – | – |
Numbers
- Publication
- 2206500
- Publication, DOCDB
- 2206500
- Publication, EPODOC
- PL2206500T
- Application
- 10159672
- Application, DOCDB
- 10159672
- Application, EPODOC
- PL20100159672T
Titles2
- English
- A solid pharmaceutical dosage formulation comprising lopinavir
- Polish
- Stała farmaceutyczna formulacja leku zawierająca lopinawir
Classification
- CPC, 19
- A61K9/1694
- A61K9/28
- A61K9/1617
- A61K9/1635
- A61K9/2009
- A61K9/2013
- A61K9/2018
- A61K9/2027
- A61K9/2031
- A61K9/204
- A61K9/2077
- A61K9/2095
- A61K9/2866
- A61K31/00
- A61K31/426
- A61K31/427
- A61K31/513
- A61K47/32
- A61P31/18
- IPC, 5
- A61K31 513
- A61K9 16
- A61K9 20
- A61K9 28
- A61K31 427